Smartwatches may transform blood sugar tracking, but today’s advances depend on CGMs, AI, and regulated health tech ...
DexCom (DXCM) faces GLP-1 disruption as it targets non-insulin Type 2 CGM growth. Read here for a detailed invesment analysis ...
AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...
AI can help read CGM data for glucose forecasts, but broader health profiling still faces validation, privacy, and governance ...
June 11 (Reuters) - Drug wholesaler Pharmsource LLC said it was unaware the Dexcom (DXCM.O), opens new tab glucose sensors it bought from licensed distributors had been slated for destruction, after ...
Add Yahoo as a preferred source to see more of our stories on Google. June 11 (Reuters) - Drug wholesaler Pharmsource LLC said it was unaware the Dexcom glucose sensors it bought from licensed ...
Dexcom received FDA clearance for its first over-the-counter continuous glucose monitor, called Stelo. The device is intended for people with Type 2 diabetes who do not take insulin. · MedTech Dive · ...
Company establishes permanent council to drive ongoing innovation guided by community feedback Report outlines targeted commitments Dexcom is making to address sentiments shared by council members ...
Editor’s note: This post was updated on June 9 to include a statment from Pharmsource. People with diabetes who use the Dexcom G7 continuous glucose monitoring system need to check the lot numbers on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results